176 related articles for article (PubMed ID: 23856826)
61. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
[TBL] [Abstract][Full Text] [Related]
62. Incidental diagnosis of diffuse large B-cell lymphoma by 11C-choline PET/CT in a patient with biochemical recurrence of prostate cancer.
Garzon JG; Bassa P; Moragas M; Soler M; Riera E
Clin Nucl Med; 2014 Aug; 39(8):742-3. PubMed ID: 24978327
[TBL] [Abstract][Full Text] [Related]
63. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
DeGrado TR; Baldwin SW; Wang S; Orr MD; Liao RP; Friedman HS; Reiman R; Price DT; Coleman RE
J Nucl Med; 2001 Dec; 42(12):1805-14. PubMed ID: 11752077
[TBL] [Abstract][Full Text] [Related]
64. Fortuitous discovery of non-fluorocholine-fixing papillary carcinoma of vesicular variant of the thyroid.
Guignard N; Chambon G; Chambert B; Najaf Y; Lallemant B
Eur Arch Otorhinolaryngol; 2019 May; 276(5):1541-1544. PubMed ID: 30868218
[TBL] [Abstract][Full Text] [Related]
65. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Basu S; Li G; Bural G; Alavi A
Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
[TBL] [Abstract][Full Text] [Related]
66. ¹¹C-Choline PET/CT in Recurrent Prostate Cancer and Nonprostatic Neoplastic Processes.
Welle CL; Cullen EL; Peller PJ; Lowe VJ; Murphy RC; Johnson GB; Binkovitz LA
Radiographics; 2016; 36(1):279-92. PubMed ID: 26761541
[TBL] [Abstract][Full Text] [Related]
67. A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
Fartoux L; Balogova S; Nataf V; Kerrou K; Huchet V; Rosmorduc O; Talbot JN
Nucl Med Commun; 2012 Jul; 33(7):757-65. PubMed ID: 22504293
[TBL] [Abstract][Full Text] [Related]
68. [The PET/CT with 18F-fluorocholine in the diagnosis of gliomatosis cerebri type 2].
Niccoli-Asabella A; Notaristefano A; Garribba MG; Rubini D; Ferrari C; Rubini G
Recenti Prog Med; 2013 Feb; 104(2):73-5. PubMed ID: 23535962
[TBL] [Abstract][Full Text] [Related]
69. Breast Cancer Incidentally Detected by 18F-Choline PET/CT in a Patient With Recurrent Prostate Carcinoma.
Vadrucci M; Gilardi L; Grana CM
Clin Nucl Med; 2016 Nov; 41(11):892-893. PubMed ID: 27607157
[TBL] [Abstract][Full Text] [Related]
70. Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images?
Hwang I; Chong A; Jung SI; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K; Ryu SB
Ann Nucl Med; 2013 Feb; 27(2):140-5. PubMed ID: 23076866
[TBL] [Abstract][Full Text] [Related]
71. ¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization.
Koo PJ; David Crawford E
Oncology (Williston Park); 2014 Dec; 28(12):1057-62, 1064-5. PubMed ID: 25738199
[TBL] [Abstract][Full Text] [Related]
72. Penile Metastasis From Prostate Cancer Detected by 18F-Fluorocholine PET/CT.
Bianchi D; Rizzo A; Bonacina M; Zaniboni A; Savelli G
Clin Nucl Med; 2021 Jan; 46(1):e38-e39. PubMed ID: 32956108
[TBL] [Abstract][Full Text] [Related]
73. Brain metastases in patient with prostate cancer found in 18F-choline PET/CT.
Gizewska A; Witkowska-Patena E; Stembrowicz-Nowakowska Z; Buraczewska A; Dziuk M
Nucl Med Rev Cent East Eur; 2015; 18(1):39-41. PubMed ID: 25633517
[TBL] [Abstract][Full Text] [Related]
74. Prostate Cancer Lytic Bone Metastases Imaged With 18F-Fluorocholine PET/CT.
Alabed YZ
Clin Nucl Med; 2018 Mar; 43(3):220-221. PubMed ID: 29356739
[TBL] [Abstract][Full Text] [Related]
75. Pulmonary neuroendocrine tumor incidentally detected by (18)F-CH PET/CT.
Treglia G; Lococo F; Petrone G; Inzani F; Perotti G; Porziella V; Granone P; Rindi G; Giordano A; Rufini V
Clin Nucl Med; 2013 Apr; 38(4):e196-9. PubMed ID: 23446117
[TBL] [Abstract][Full Text] [Related]
76. Radiation dosimetry of 18F-fluorocholine PET/CT studies in prostate cancer patients.
Fabbri C; Galassi R; Moretti A; Sintuzzi E; Mautone V; Sarti G; Strigari L; Benassi M; Matteucci F
Phys Med; 2014 May; 30(3):346-51. PubMed ID: 24238928
[TBL] [Abstract][Full Text] [Related]
77. Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer.
Kwee S; Song MA; Cheng I; Loo L; Tiirikainen M
Clin Transl Sci; 2012 Feb; 5(1):65-70. PubMed ID: 22376260
[TBL] [Abstract][Full Text] [Related]
78. 18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer.
De Leiris N; Riou L; Leenhardt J; Vuillez JP; Djaileb L
Clin Nucl Med; 2018 Dec; 43(12):e471-e472. PubMed ID: 30300202
[TBL] [Abstract][Full Text] [Related]
79. Ectopic Salivary Gland in a Patient With Prostate Cancer at 18F-Choline PET/CT: An Incidental Finding.
Cuppari L; Evangelista L
Clin Nucl Med; 2018 Aug; 43(8):593-594. PubMed ID: 29847318
[TBL] [Abstract][Full Text] [Related]
80. Incidental Detection of Plasma Cell Neoplasm on 18F-Choline PET/CT Imaging.
Paudel J; Singla N; Bhattacharya A; Basher RK; Mittal BR
Clin Nucl Med; 2019 Feb; 44(2):140-141. PubMed ID: 30562192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]